MedTrace Logo

Effects of Androgen Administration on Inflammation in Normal Women

NCT01753037 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-11-18

No results posted yet for this study

Summary

The hypothesis of this study is that DHEA administration to increase male hormone in healthy normal-weight young women to levels present in women with Polycystic Ovary Syndrome will cause an inflammatory response in white blood cells in the fasting state, and in response to glucose ingestion.

Conditions

  • Hyperandrogenism

Interventions

DIETARY_SUPPLEMENT

Dehydroepiandrosterone (DHEA)

DHEA 130 mg administered orally for 5 days.

OTHER

Placebo

Placebo contained in a capsule that is identical in appearance to the one used to package DHEA for 5 days.

Sponsors & Collaborators

Principal Investigators

  • Frank González, M.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01753037 on ClinicalTrials.gov